Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.2K

Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades

Xinhua Qu1, Zanjing Zhai1, Xuqiang Liu1

  • 1Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Biochemical and Biophysical Research Communications
|December 17, 2013
PubMed

Insights

Dioscin effectively inhibits osteoclast formation and bone resorption by targeting the Akt/NF-κB pathway. This natural compound shows promise for treating bone diseases like osteoporosis and metastasis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoclasts (OCs) are crucial for bone remodeling but implicated in diseases like osteoporosis.
  • Targeting OC formation and function is a key strategy for treating bone pathologies.
  • Natural compounds offer potential therapeutic avenues for osteoclast-related disorders.

Purpose of the Study:

  • To investigate the effects of dioscin on osteoclast differentiation and bone resorption.
  • To elucidate the molecular mechanisms underlying dioscin's action on osteoclasts.
  • To evaluate dioscin's therapeutic potential in vivo for bone diseases.

Main Methods:

  • In vitro studies on RANKL-induced osteoclast differentiation and bone resorption assays.
  • Analysis of osteoclast-specific marker expression.
  • Western blot analysis to assess AKT phosphorylation and NF-κB signaling.
  • In vivo studies using an osteolytic animal model.

Main Results:

  • Dioscin dose-dependently suppressed osteoclast differentiation and bone resorption in vitro.
  • Dioscin reduced the expression of osteoclast-specific markers.
  • Dioscin inhibited AKT phosphorylation, impaired RANKL-induced NF-κB signaling, and reduced NFATc1 activity.
  • In vivo studies confirmed dioscin's bone protective effects in an osteolytic model.

Conclusions:

  • Dioscin suppresses RANKL-induced osteoclast formation and function via the Akt signaling pathway.
  • Dioscin demonstrates significant potential as a natural therapeutic agent for osteoclast-related diseases.
  • Further research into dioscin could lead to novel treatments for osteoporosis and bone metastasis.
Keywords:
AKT cascadesDioscinOsteoclastOsteolysis

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

3.9K
Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.7K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K